Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSThree Regulatory News (STEM)

Share Price Information for SThree (STEM)

Share Price is delayed by 15 minutes
Get Live Data
170.20    -0.20 (-0.12%)
Bid:
170.40
Ask:
171.00
Spread: 0.60 (0.352%)
Market Cap: £208.86m
STEM Live PriceLast checked at - London Stock Exchange

Intraday SThree Share Chart

Directorate Change

2 Apr 2024 12:10

RNS Number : 9781I
SThree plc
02 April 2024
 

2 April 2024

 

SThree plc

 

Directorate Change

 

SThree plc, the only global specialist talent partner focused on roles in Science, Technology, Engineering and Mathematics (STEM), is pleased to announce that it will appoint Sanjeevan Bala as an Independent Non-Executive Director with effect from the conclusion of the Annual General Meeting on 25 April 2024, in line with its previously stated plan to recruit a new Non-Executive.

 

Sanjeevan has extensive experience driving customer-centric technology transformation, having most recently been responsible for driving the digital data and AI transformation of the UK's largest commercial broadcaster and media company, ITV plc as the Group Chief Data and AI Officer. Prior to this, Sanjeevan was Head of Data Science at Channel 4 and held senior roles at Clear Cell Group and Dunhumby, a global leader in Customer Data Science.

 

Sanjeevan is currently a Non-Executive Director and the Designated Workforce Engagement NED at Bakkavor Group plc, Co-Chair of the Chief Data and AI Office Board at Evanta, a Gartner Company and on the Advisory Board of DataIQ.

 

On joining the Board, Sanjeevan will also be appointed as a member of the Audit & Risk, Nominations and Remuneration Committees.

 

James Bilefield, Chairman, commented: 

 

"I am delighted to welcome Sanjeevan to SThree and the Board. Sanjeevan is a highly experienced multi award-winning data and analytics professional with a proven track record of driving customer-centric business transformations through the strategic use of data. He brings with him extensive strategic and commercial experience which will be particularly relevant as we continue to roll out our Technology Improvement Programme, positioning us as game-changers in the market and demonstrating our ambition to be digital-first innovators. We look forward to working with him as the Group continues to execute its growth strategy."

 

 

Sanjeevan Bala commented:

 

"Having spent most of my career in STEM and witnessing first-hand the global demand for these skills expand exponentially, it feels like an incredibly exciting time to be joining SThree. The SThree team talks to global megatrends that underpin the demand for STEM and flexible talent and they couldn't be more correct. I look forward to working with the Board and forward-thinking leadership team to capitalise on this structural opportunity."

 

Notes:

This disclosure is given in accordance with LR 9.6.11 R of the Listing Rules. There is no further information to be disclosed pursuant to Listing Rule 9.6.13. 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPUAUCUPCGGP
Date   Source Headline
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 20259:59 amRNSTotal Voting Rights
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTransaction in Own Shares
29th Jan 20257:00 amRNSTransaction in Own Shares
28th Jan 20257:00 amRNSFY24 Final Results
28th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares
24th Jan 202510:10 amRNSDirectorate Change
24th Jan 20257:00 amRNSTransaction in Own Shares
23rd Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
21st Jan 20257:00 amRNSTransaction in Own Shares
20th Jan 20257:00 amRNSTransaction in Own Shares
17th Jan 20257:00 amRNSTransaction in Own Shares
16th Jan 20257:00 amRNSTransaction in Own Shares
15th Jan 20257:00 amRNSTransaction in Own Shares
14th Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20253:28 pmRNSDirector/PDMR Shareholding
13th Jan 20257:00 amRNSTransaction in Own Shares
10th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
7th Jan 20257:00 amRNSTransaction in Own Shares
6th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
2nd Jan 20254:05 pmRNSTotal Voting Rights
2nd Jan 20257:00 amRNSTransaction in Own Shares
31st Dec 20247:00 amRNSTransaction in Own Shares
30th Dec 20247:00 amRNSTransaction in Own Shares
27th Dec 20247:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSCommencement of Share Buyback
17th Dec 20249:11 amRNSDirector/PDMR Shareholding
12th Dec 20244:49 pmRNSDirector/PDMR Shareholding
12th Dec 20247:00 amRNSTrading Update
10th Dec 20241:15 pmRNSDirector/PDMR Shareholding
19th Nov 20243:01 pmRNSHolding(s) in Company
14th Nov 202412:30 pmRNSDirector/PDMR Shareholding
13th Nov 202410:05 amRNSDirector/PDMR Shareholding
1st Nov 20249:28 amRNSTotal Voting Rights
14th Oct 20245:19 pmRNSDirector/PDMR Shareholding
1st Oct 202410:10 amRNSTotal Voting Rights
25th Sep 20243:07 pmRNSDirector/PDMR Shareholding
24th Sep 20247:00 amRNSFY24 Q3 Trading Update
16th Sep 20243:00 pmRNSDirector/PDMR Shareholding
3rd Sep 20244:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.